Tommy G. Thompson, Director at TherapeuticsMD, Inc. (TXMD), bought 325 shares at $1.00 ($325) on 2025-04-14, disclosed to the SEC on 2025-04-15.
Open-market purchase of $325 TXMD by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| TXMD | BUY | 2025-12-29 | $14K | — | Filing → |
| UTHR | SELL | 2025-12-19 | $911K | — | Filing → |
| UTHR | SELL | 2025-09-10 | $3.7M | — | Filing → |